MADIT-CRT Data Support Expanded Cardiac Resynchronization Market
This article was originally published in The Pink Sheet Daily
Executive Summary
The results show that cardiac resynchronization defibrillators "slow the progression of heart failure in asymptomatic and mildly symptomatic patients," potentially expanding the market by $600 million.